Rubius Therapeutics, Inc.

BAILLIE GIFFORD & CO

Report date

12/31/2022

Quarter

2022 Q4

Filed

3/10/2023

Shares

4,869,126

Value ($000)

838

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	3/10/2023	838	0.0%	4,869,126	12/31/2022
2022 Q3	10/27/2022	2,105	0.0%	4,853,773	9/30/2022
2022 Q2	8/8/2022	4,174	0.0%	4,906,078	6/30/2022
2022 Q1	5/5/2022	27,039	0.0%	4,907,471	3/31/2022
2021 Q4	1/20/2022	47,730	0.0%	4,930,859	12/31/2021
2021 Q3	10/19/2021	83,927	0.0%	4,693,832	9/30/2021
2021 Q2	8/2/2021	114,605	0.1%	4,695,022	6/30/2021
2021 Q1	5/6/2021	124,388	0.1%	4,693,871	3/31/2021
2020 Q4	2/10/2021	35,749	0.0%	4,710,061	12/31/2020
2020 Q3	11/12/2020	21,413	0.0%	4,273,861	9/30/2020
2020 Q2	8/12/2020	25,444	0.0%	4,254,732	6/30/2020
2020 Q1	5/8/2020	18,943	0.0%	4,256,900	3/31/2020
2019 Q4	2/10/2020	40,390	0.0%	4,251,470	12/31/2019